Solvay and Watson fight US FTC and claim Androgel settlements are legal
11 August 2009
Nancy Faigen
Solvay Pharmaceuticals and
Watson Pharmaceuticals have jointly filed a motion seeking dismissal of the US Federal Trade Commission's January 29th lawsuit alleging that patent settlements over the testosterone supplement Androgel restrained competition. The companies argue that the settlements are...
Please Login to read the full article.
11 August 2009
Nancy Faigen
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: 11th Circuit's severability ruling could save data exclusivity from another fight
- DC Circuit upholds health care reform law as constitutional
- US feds not losing any sleep over Sanofi Ambien generic deal violations
- Supreme Court rules against statistically significant 'bright-line' rule in Matrixx
COMMENT
Other Informa Comment
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
